Ronald T. Ackermann

6.8k total citations · 2 hit papers
116 papers, 4.4k citations indexed

About

Ronald T. Ackermann is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Pharmacy. According to data from OpenAlex, Ronald T. Ackermann has authored 116 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 34 papers in General Health Professions and 28 papers in Pharmacy. Recurrent topics in Ronald T. Ackermann's work include Diabetes Management and Education (48 papers), Obesity and Health Practices (28 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). Ronald T. Ackermann is often cited by papers focused on Diabetes Management and Education (48 papers), Obesity and Health Practices (28 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). Ronald T. Ackermann collaborates with scholars based in United States, Canada and Philippines. Ronald T. Ackermann's co-authors include David G. Marrero, William H. Herman, Emily Finch, Robert E. Ratner, Ping Zhang, Edward J. Brizendine, Haiyu Zhou, Michael M. Engelgau, Thomas J. Hoerger and Matthew J. O’Brien and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Ronald T. Ackermann

112 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance

2005 501 citations William H. Herman, Thomas J. Hoerger et al. profile →
The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up

2015 282 citations Sharon L. Edelstein, William H. Herman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald T. Ackermann United States	34	2.0k	1.1k	823	689	685	116	4.4k
A. Fagot‐Campagna France	39	2.4k 1.2×	752 0.7×	1.1k 1.3×	977 1.4×	751 1.1×	161	6.0k
Kai McKeever Bullard United States	37	2.1k 1.0×	886 0.8×	743 0.9×	944 1.4×	462 0.7×	101	5.4k
Rebecca K. Simmons United Kingdom	39	2.2k 1.1×	586 0.5×	1.4k 1.6×	845 1.2×	992 1.4×	104	4.8k
Nilka Rı́os Burrows United States	38	2.1k 1.0×	693 0.6×	904 1.1×	793 1.2×	537 0.8×	78	5.9k
Sarah Stark Casagrande United States	24	1.6k 0.8×	517 0.5×	865 1.1×	596 0.9×	692 1.0×	55	4.1k
Justin B. Echouffo‐Tcheugui United States	47	3.0k 1.5×	666 0.6×	1.2k 1.5×	1.2k 1.7×	1.0k 1.5×	248	7.8k
Stewart B. Harris Canada	43	3.2k 1.6×	1.2k 1.1×	1.3k 1.6×	811 1.2×	1.1k 1.6×	208	7.0k
Tom A. Elasy United States	41	2.8k 1.4×	2.1k 2.0×	1.2k 1.4×	1.1k 1.7×	582 0.8×	114	6.7k
T. Kue Young Canada	33	1.3k 0.6×	728 0.7×	775 0.9×	703 1.0×	501 0.7×	67	3.9k
Dianna J. Magliano Australia	36	1.7k 0.9×	559 0.5×	1.5k 1.9×	888 1.3×	1.4k 2.0×	108	6.0k

Countries citing papers authored by Ronald T. Ackermann

Since Specialization

Citations

This map shows the geographic impact of Ronald T. Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald T. Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald T. Ackermann more than expected).

Fields of papers citing papers by Ronald T. Ackermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald T. Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald T. Ackermann. The network helps show where Ronald T. Ackermann may publish in the future.

Co-authorship network of co-authors of Ronald T. Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald T. Ackermann. A scholar is included among the top collaborators of Ronald T. Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald T. Ackermann. Ronald T. Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chorniy, Anna, et al.. (2025). Comparing Predictive Power of Area-Level Socioeconomic Status Indices Across Health Outcomes and Geographic Levels. Medical Care. 64(2). 77–88.

Herman, William H., Tannaz Moin, Laura N. McEwen, et al.. (2025). Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program. AJPM Focus. 4(6). 100401–100401.

O’Connor, Mary, John Devin Peipert, Sofia F. Garcia, et al.. (2024). Implementation of a Co-Design Strategy to Develop a Dashboard to Support Shared Decision Making in Advanced Cancer and Chronic Kidney Disease. Journal of Clinical Medicine. 13(14). 4178–4178. 1 indexed citations

Ackermann, Ronald T., Namratha R. Kandula, Kenzie A. Cameron, et al.. (2023). Design and rationale of behavioral nudges for diabetes prevention (BEGIN): A pragmatic, cluster randomized trial of text messaging and a decision aid intervention for primary care patients with prediabetes. Contemporary Clinical Trials. 130. 107216–107216. 2 indexed citations

Horn, Linda Van, et al.. (2023). Menu Calorie Label Use and Diet Quality: a Cross-Sectional Study. American Journal of Preventive Medicine. 65(6). 1069–1077. 5 indexed citations

O’Brien, Matthew J., Stacy Cooper Bailey, Dyanna L. Gregory, et al.. (2023). Screening for Prediabetes and Diabetes in a National Network of Federally Qualified Health Centers: An Observational Study. Journal of General Internal Medicine. 38(16). 3541–3548. 2 indexed citations

Wallia, Amisha, Matthew J. O’Brien, Raymond Kang, et al.. (2023). Comparative cardiovascular effects of GLP‐1 agonists using real‐world data. Endocrinology Diabetes & Metabolism. 6(3). e339–e339. 3 indexed citations

O’Brien, Matthew J., Yan Zhang, Stacy Cooper Bailey, et al.. (2023). Clinical performance and health equity implications of the American Diabetes Association’s 2023 screening recommendation for prediabetes and diabetes. Frontiers in Endocrinology. 14. 1279348–1279348.

Meurer, John, et al.. (2023). Online Appendix for A Comparative Assessment of Measures of Area-Level Socio-Economic Status. SSRN Electronic Journal. 1 indexed citations

10.

Kandula, Namratha R., Veronica Bernard, Swapna S. Dave, et al.. (2020). The South Asian Healthy Lifestyle Intervention (SAHELI) trial: Protocol for a mixed-methods, hybrid effectiveness implementation trial for reducing cardiovascular risk in South Asians in the United States. Contemporary Clinical Trials. 92. 105995–105995. 10 indexed citations

11.

Ackermann, Ronald T., Amisha Wallia, Raymond Kang, et al.. (2017). Comparative effectiveness and costs of insulin pump therapy for diabetes.. The American Journal of Managed Care. 23(6). 353–359. 5 indexed citations

12.

Finch, Emily, et al.. (2017). A pragmatic randomized comparative effectiveness trial of transitional care for a socioeconomically diverse population: Design, rationale and baseline characteristics. Contemporary Clinical Trials. 65. 53–60. 4 indexed citations

13.

O’Brien, Matthew J., Ji Young Lee, Mercedes R. Carnethon, et al.. (2016). Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients. PLoS Medicine. 13(7). e1002074–e1002074. 24 indexed citations

14.

Ackermann, Ronald T., Ann Holmes, & Chandan Saha. (2013). Designing a Natural Experiment to Evaluate a National Health Care–Community Partnership to Prevent Type 2 Diabetes. Preventing Chronic Disease. 10. E12–E12. 10 indexed citations

15.

Herman, William H., Sharon L. Edelstein, Robert E. Ratner, et al.. (2013). Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.. PubMed. 19(3). 194–202. 71 indexed citations

16.

Zhuo, Xiaohui, Ping Zhang, Elizabeth Selvin, et al.. (2012). Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention. American Journal of Preventive Medicine. 42(4). 374–381. 29 indexed citations

17.

Ackermann, Ronald T., et al.. (2010). Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabetic Medicine. 27(5). 578–584. 55 indexed citations

18.

Ackermann, Ronald T., Yiling J. Cheng, David F. Williamson, & Edward W. Gregg. (2010). Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c. American Journal of Preventive Medicine. 40(1). 11–17. 72 indexed citations

19.

Nguyen, Huong Q., Ronald T. Ackermann, Matthew L. Maciejewski, et al.. (2008). Managed-Medicare health club benefit and reduced health care costs among older adults.. PubMed. 5(1). A14–A14. 122 indexed citations

20.

Nguyen, Huong Q., Ronald T. Ackermann, Matthew L. Maciejewski, et al.. (2008). Peer Reviewed: Managed-Medicare Health Club Benefit and Reduced Health Care Costs Among Older Adults. Preventing Chronic Disease. 5(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact